Trevena
TRVN
$0.39
Share price
-4.40%
Change (1 day)
-39.85%
Change (1 year)
Categories
Operating Margin for Trevena (TRVN)
Operating Margin as of April 2024 (TTM): -24,856.30%
According to Trevena's latest financial reports and stock price the company's current Operating Margin is -24,856.30%. At the end of 2021 the company had an Operating Margin of -9,098.41%.
Operating Margin history for Trevena from 2013 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -9,098.41% | 860.58% |
| 2020 | -947.18% | -98.82% |
| 2019 | -80,229.03% | 15209.19% |
| 2018 | -524.06% | |
| 2016 | -2,746.51% | 239.72% |
| 2015 | -808.45% | |
| 2013 | -17,225.84% | 789.73% |
| 2012 | -1,936.08% | 196.52% |
| 2011 | -652.93% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | 34.59% | -100.14% | 🇺🇸 USA |
 Merck MRK | 27.73% | -100.11% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | -79.07% | -99.68% | 🇺🇸 USA |
 Cytokinetics
CYTK | -5,422.18% | -78.19% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | 0.00% | N/A | 🇺🇸 USA |
 Cara Therapeutics
CARA | -209.07% | -99.16% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.